21 Reviewed Antidepressants Top Placebo for Major Depression

This article originally appeared here.
Share this content:
21 Reviewed Antidepressants Top Placebo for Major Depression
21 Reviewed Antidepressants Top Placebo for Major Depression

THURSDAY, Feb. 22, 2018 (HealthDay News) -- For adults with major depressive disorder, all antidepressants are more efficacious than placebo, according to research published online Feb. 21 in The Lancet.

Andrea Cipriani, M.D., from the University of Oxford in the United Kingdom, and colleagues conducted a systematic review and meta-analysis to compare and rank 21 antidepressants used for the acute treatment of adults with unipolar major depressive disorder. Data were included from 522 trials with 116,477 participants.

The researchers found that all antidepressants were more effective than placebo in terms of efficacy, with odds ratios ranging from 2.13 for amitriptyline to 1.37 for reboxetine. Only agomelatine and fluoxetine correlated with fewer dropouts than placebo in terms of acceptability (odds ratios, 0.84 and 0.88, respectively), while clomipramine was worse than placebo (odds ratio, 1.30). Considering all trials, the between-antidepressant differences in odds ratios varied from 1.15 to 1.55 for efficacy and from 0.64 to 0.83 for acceptability. In head-to-head studies, the most effective antidepressants were agomelatine, amitriptyline, escitalopram, mirtazapine, paroxetine, venlafaxine, and vortioxetine, while the least efficacious were fluoxetine, fluvoxamine, reboxetine, and trazodone. Compared with other antidepressants, agomelatine, citalopram, escitalopram, fluoxetine, sertraline, and vortioxetine were more tolerable, while the highest dropout rates were seen for amitriptyline, clomipramine, duloxetine, fluvoxamine, reboxetine, trazodone, and venlafaxine.

"These results should serve evidence-based practice and inform patients, physicians, guideline developers, and policy makers on the relative merits of the different antidepressants," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

High Success Rates for Mitral Valve Repair With Robotic Surgery

High Success Rates for Mitral Valve Repair With ...

Minimally invasive surgery linked to fewer discharges to facility, one day less in hospital vs conservative sx

Tattoo-Linked Complications ID'd in Immunosuppressed Female

Tattoo-Linked Complications ID'd in Immunosuppressed Female

Inflammatory myopathy identified in woman with cystic fibrosis on long-term immunosuppressants

Rates of Cardiac Stress Testing Down but Still Higher in CKD

Rates of Cardiac Stress Testing Down but Still ...

Decline in rates of cardiac stress testing in Medicare beneficiaries aged ≥66 years from 2008 to 2012

is free, fast, and customized just for you!




Already a member?

Sign In Now »